To create first in class small molecule therapeutics using proprietary, industry leading molecular modeling methods and systems biology technologies
Gero is a team of 26 professionals, 8 of them have Ph. D. degree. The experts came to Gero from diverse fields of studies - theoretical physics, drug discovery and development, and IT business. The scientific effort is led by Dr. Peter Fedichev, a former condensed matter physicist, and an international group of biologists, medicinal chemists and computer science experts.